2-benzylidene-1-indanone derivatives for acute lung injury
5. Imam F, Al-Harbi NO, Al-Harbi MM, et al. Diosmin downregulates the
expression of T cell receptors, pro-inflammatory cytokines and NF-κB
activation against LPS-induced acute lung injury in mice. Pharmacol
Res. 2015;102(1):1–11.
6. Qi T, Xu F, Yan X, Li S, Li H. Sulforaphane exerts anti-inflammatory
effects against lipopolysaccharide-induced acute lung injury in mice
through the Nrf2/ARE pathway. Int J Mol Med. 2016;37(1):182–188.
7. Merrill JC, You J, Constable C, Leeman SE, Amar S. Whole-body
deletion of LPS-induced TNF-α factor (LITAF) markedly improves
experimental endotoxic shock and inflammatory arthritis. Proc Natl
Acad Sci U S A. 2011;108(52):21247–21252.
8. Lee IS, Lim J, Gal J, et al. Anti-inflammatory activity of xanthohumol
involves heme oxygenase-1 induction via NRF2-ARE signaling in
microglial BV2 cells. Neurochem Int. 2011;58(2):153–160.
9. Viola K, Kopf S, Rarova L, et al. Xanthohumol attenuates tumour
cell-mediated breaching of the lymphendothelial barrier and prevents
intravasation and metastasis. Arch Toxicol. 2013;87(7):1301–1312.
10. Yong WK, Ho YF, Malek SN. Xanthohumol induces apoptosis and
S phase cell cycle arrest in A549 non-small cell lung cancer cells.
Pharmacogn Mag. 2015;11(Suppl 2):275–283.
19. Singh A, Fatima K, Singh A, et al. Anticancer activity and toxicity
profiles of 2-benzylidene indanone lead molecule. Eur J Pharm Sci.
2015;76(8):57–67.
20. Shintani EY, Uchida KM. Donepezil: an anticholinesterase inhibi-
tor for Alzheimer’s disease. Am J Health Syst Pharm. 1997;54(24):
2805–2810.
21. Zhu H, Xu T, Qiu C, et al. Synthesis and optimization of novel ally-
lated mono-carbonyl analogs of curcumin (MACs) act as potent anti-
inflammatory agents against LPS-induced acute lung injury (ALI) in
rats. Eur J Med Chem. 2016;121:181–193.
22. Liu Z, Tang L, Zou P, et al. Synthesis and biological evaluation of
allylated and prenylated mono-carbonyl analogs of curcumin as anti-
inflammatory agents. Eur J Med Chem. 2014;74(3):671–682.
23. Bueltmann M, Kong X, Mertens M, et al. Inhaled milrinone attenu-
ates experimental acute lung injury. Intensive Care Med. 2009;35(1):
171–178.
24. Tsai YF, Yu HP, Chang WY, Liu FC, Huang ZC, Hwang TL. Sirtinol
inhibits neutrophil elastase activity and attenuates lipopolysaccharide-
mediated acute lung injury in mice. Sci Rep. 2015;5:8347–8356.
25. Mogensen TH. Pathogen recognition and inflammatory signaling in
innate immune defenses. Clin Microbiol Rev. 2009;22(2):240–273.
26. Franz KM, Kagan JC. Innate immune receptors as competitive deter-
minants of cell fate. Mol Cell. 2017;66(6):750–760.
11. Hartkorn A, Hoffmann F, Ajamieh H, et al. Antioxidant effects of
xanthohumol and functional impact on hepatic ischemia-reperfusion
injury. J Nat Prod. 2009;72(10):1741–1747.
12. Costa R, Rodrigues I, Guardão L, et al. Modulation of VEGF signaling
in a mouse model of diabetes by xanthohumol and 8-prenylnaringenin:
Unveiling the angiogenic paradox and metabolism interplay. Mol Nutr
Food Res. 2017;61(4).
13. Costa R, Negrão R, Valente I, et al. Xanthohumol modulates inflam-
mation, oxidative stress, and angiogenesis in type 1 diabetic rat skin
wound healing. J Nat Prod. 2013;76(11):2047–2053.
14. Cho YC, You SK, Kim HJ, Cho CW, Lee IS, Kang BY. Xanthohumol
inhibits IL-12 production and reduces chronic allergic contact derma-
titis. Int Immunopharmacol. 2010;10(5):556–561.
27. Bednash JS, Weathington N, Londino J, et al. Targeting the deubiquit-
inase STAMBP inhibits NALP7 inflammasome activity. Nat Commun.
2017;8:15203–15216.
28. Zhou Y, Liu T, Duan JX, et al. Soluble epoxide hydrolase inhibitor
attenuates lipopolysaccharide-induced acute lung injury and improves
survival in mice. Shock. 2017;47(5):638–645.
29. Liu Z, Tang L, Zhu H, et al. Design, synthesis, and structure-activity
relationship study of novel indole-2-carboxamide derivatives as anti-
inflammatory agents for the treatment of sepsis. J Med Chem. 2016;
59(10):4637–4650.
15. Avula B, Ganzera M, Warnick JE, Feltenstein MW, Sufka KJ,
Khan IA. High-performance liquid chromatographic determination of
xanthohumol in rat plasma, urine, and fecal samples. J Chromatogr Sci.
2004;42(7):378–382.
30. Joh EH, Gu W, Kim DH. Echinocystic acid ameliorates lung inflam-
mation in mice and alveolar macrophages by inhibiting the binding of
LPS to TLR4 in NF-κB and MAPK pathways. Biochem Pharmacol.
2012;84(3):331–340.
16. Butkevich AN, Ranieri B, Meerpoel L, et al. Synthesis of substituted
indenones and indanones by a Suzuki–Miyaura coupling/acid-promoted
cyclisation sequence. Org Biomol Chem. 2014;12(5):728–731.
17. Tang ML, Zhong C, Liu ZY, Peng P, Liu XH, Sun X. Discovery of
novel sesquistilbene indanone analogues as potent anti-inflammatory
agents. Eur J Med Chem. 2016;113(5):63–74.
31. Jeong DH, Kim KB, Kim MJ, Kang BK, Ahn DH. Skipjack tuna
(Katsuwonus pelamis) eyeball oil exerts an anti-inflammatory effect by
inhibiting NF-κB and MAPK activation in LPS-induced RAW 264.7
cells and croton oil-treated mice. Int Immunopharmacol. 2016;40(11):
50–56.
18. Shrestha A, Jin Oh H, Kim MJ, et al. Design, synthesis, and structure-
activity relationship study of halogen containing 2-benzylidene-
1-indanone derivatives for inhibition of LPS-stimulated ROS
production in RAW 264.7 macrophages. Eur J Med Chem. 2017;133(6):
121–138.
Drug Design, Development and erapy
Publish your work in this journal
Drug Design, Development and Therapy is an international, peer-
reviewed open-access journal that spans the spectrum of drug design
and development through to clinical applications. Clinical outcomes,
patient safety, and programs for the development and effective, safe,
and sustained use of medicines are the features of the journal, which
has also been accepted for indexing on PubMed Central. The manu-
script management system is completely online and includes a very
quick and fair peer-review system, which is all easy to use. Visit
published authors.
Drug Design, Development andTherapy 2018:12
899